Tang Capital Management’s Pardes Biosciences, Inc. Common Stock PRDS Stock Holding History

Tang Capital Management’s Portfolio PRDS Stock Details PRDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,945,206	Closed	-$3.52M	–	116
2023 Q2	$3.52M	Buy	1,945,206 +1,645,206	+548%	+$3.01M	0.52%	53
2023 Q1	$396K	Buy	300,000 +266,252	+789%	+$435K	0.06%	88
2022 Q4	$57K	Sell	33,748 -466,252	-93%	-$591K	0.01%	89
2022 Q3	$925K	Buy	500,000 +364,037	+268%	+$1.09M	0.11%	86
2022 Q2	$417K	Buy	+135,963	New	+$830K	0.06%	65

Other funds holding PRDS

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Tang Capital Management's PRDS Position: Q3 2023 in Review

Tang Capital Management sold out of Pardes Biosciences, Inc. Common Stock (PRDS) in Q3 2023, closing a stake of 1,945,206 shares — an estimated $3.52M sold.

Tang Capital Management first reported a position in PRDS in Q2 2022 and held it in 5 quarters. The position peaked at $3.52M in Q2 2023. 1 fund tracked by Wall St. Rank holds PRDS as of Q3 2023.

Tang Capital Management reported no remaining Pardes Biosciences, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Tang Capital Management sold 1,945,206 Pardes Biosciences, Inc. Common Stock shares in Q3 2023, an estimated $3.52M.
Tang Capital Management first reported a position in Pardes Biosciences, Inc. Common Stock in Q2 2022 and held it in 5 quarters.
Tang Capital Management's Pardes Biosciences, Inc. Common Stock position peaked at $3.52M in Q2 2023.
1 fund tracked by Wall St. Rank held Pardes Biosciences, Inc. Common Stock as of Q3 2023.

Based on Tang Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.